These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6164799)

  • 1. Testis tumor markers: how accurate are they?
    deVere White R; Karian S; Hong WK; Olsson CA
    J Urol; 1981 May; 125(5):661-3. PubMed ID: 6164799
    [No Abstract]   [Full Text] [Related]  

  • 2. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
    Lo RK; Johnson DE
    J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
    Fossa SD; Paus E
    Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence of biochemical markers in a complex diagnostico-therapeutic program in germ cell tumors of the testes].
    Abrahámová J; Motlík K; Malbohan I; Wernischová V
    Cas Lek Cesk; 1983 Jul; 122(26):824-9. PubMed ID: 6193884
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ; Williams JJ
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
    [No Abstract]   [Full Text] [Related]  

  • 9. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers aid therapy of testicular cancer.
    JAMA; 1979 Jul; 242(4):320-1. PubMed ID: 87526
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
    Dunzendorfer U; Jurincic C
    Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An unusual seminoma].
    Deminière C; Paradis V; Vieillefond A; Savin de Larclause AM; Morard JL
    Ann Pathol; 1994; 14(2):127-8. PubMed ID: 7515236
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
    Uysal Z; Bakkaloğlu M
    Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemistry of germ cell tumors of the testis. Study of beta HCG and AFP.
    Caillaud JM; Bellet D; Carlu C; Droz JP
    Prog Clin Biol Res; 1985; 203():139-40. PubMed ID: 2421327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
    Mumperow E; Kressel K; Hartmann M
    Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S; Arakawa S; Masuda M; Hamami G; Shimatani N; Itho N; Nakatsuka E; Fujii A; Ohono S; Ishigami J; Yoshimoto Y; Hattori M; Fujita T; Okada S
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):352-62. PubMed ID: 6157042
    [No Abstract]   [Full Text] [Related]  

  • 20. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
    Mumperow E; Hartmann M
    J Urol; 1992 Apr; 147(4):1041-3. PubMed ID: 1372658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.